Government Trades

Overview
Securities
Members
States
Chambers
Committees
Parties

Vertex Pharmaceuticals Inc

(NASDAQ:VRTX)
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

top performing VRTX trades

William Keating headshot
William Keating
House (D-MA)
53.20%
Tommy Tuberville headshot
Tommy Tuberville
Senate (R-AL)
31.20%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Vertex Pharmaceuticals trades made by congress members.
Tommy TubervilleSenate (R-AL)
$1K - $15KstockSaleJun 14, 2024May 03, 2024
Senate
Greg StantonHouse (D-AZ)
$1K - $15KstockSaleNov 09, 2023Oct 24, 2023
House
Greg StantonHouse (D-AZ)
$1K - $15KstockPurchaseNov 09, 2023Sep 26, 2023
House
Tommy TubervilleSenate (R-AL)
$1K - $15KstockPurchaseNov 10, 2022Oct 06, 2022
Senate
William KeatingHouse (D-MA)
$1K - $15KstockPurchaseMay 05, 2022Mar 29, 2022
House